Product complaint # (b)(4).Dmf#: (b)(6), trade name: gentamicin sulphate, active ingredient(s): gentamicin sulphate, dosage form: powder, strength 1.0g active in our cements.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
Clinical adverse event received for patch of synovitis lateral aspect of left knee.Event is not serious and is considered mild.Event is not related to device and possibly related to procedure.Date of implant: (b)(6) 2018, date of event: (b)(6) 2021, (left knee).Treatment: unspecified injected medication and diagnostic intervention.
|
Product complaint # (b)(4).Investigation summary no device associated with this report was received for examination.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Depuy considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation will be re-opened as necessary.Device history lot the product investigation found no evidence suspecting an error in the manufacturing or material that would be a contributing factor in the reported allegation(s).A manufacturing records evaluation (mre) was not performed.
|